Long-standing IBD is associated with an increased risk of neoplasia. Chromoendoscopy was proven to be the most sensitive modality for dysplasia detection in several clinical trials, but a new study has now shown it to be an effective screening strategy in a routine clinical setting, further warranting its implementation into real-world practice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Kiesslich, R. et al. Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis. Gastroenterology 124, 880–888 (2003).
Subramanian, V., Mannath, J., Ragunath, K. & Hawkey, C. J. Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease. Aliment. Pharmacol. Ther. 33, 304–312 (2011).
Annese, V. et al. European evidence based consensus for endoscopy in inflammatory bowel disease. J. Crohns Colitis 7, 982–1018 (2013).
Farraye, F. A. et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138, 738–745 (2010).
Carballal, S. et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut http://dx.doi.org/10.1136/gutjnl-2016-312332, (2016).
Marion, J. F. et al. Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial. Am. J. Gastroenterol. 103, 2342–2349 (2008).
Picco, M. F. et al. Procedure time and the determination of polypoid abnormalities with experience: implementation of a chromoendoscopy program for surveillance colonoscopy for ulcerative colitis. Inflamm. Bowel Dis. 19, 1913–1920 (2013).
Laine, L. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastroenterology 148, 639–651 (2015).
Mooiweer, E. et al. Chromoendoscopy for surveillance in inflammatory bowel disease does not increase neoplasia detection compared with conventional colonoscopy with random biopsies: results from a large retrospective study. Am. J. Gastroenterol. 110, 1014–1021 (2015).
Marion, J. F. et al. Chromoendoscopy is more effective than standard colonoscopy in detecting dysplasia during long-term surveillance of patients with colitis. Clin. Gastroenterol. Hepatol. 14, 713–719 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.A. has served as adviser to AbbVie, InDex Pharmaceuticals and Takeda. M.F.N. has served as adviser to AbbVie, Boehringer Ingelheim, Genentech, Giuliani, Janssen, MSD, Pentax and Takeda.
Rights and permissions
About this article
Cite this article
Atreya, R., Neurath, M. Chromoendoscopy in IBD: indispensable in real-life screening. Nat Rev Gastroenterol Hepatol 13, 688–690 (2016). https://doi.org/10.1038/nrgastro.2016.184
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2016.184
